• Explore /
  • Poster
  • / <span>Effect of autologous lymphocytes combined with chemotherapy as the first-line treatment of advanced gastric cancer.</span>

Effect of autologous lymphocytes combined with chemotherapy as the first-line treatment of advanced gastric cancer.

Abstract Video & Slides Poster

Authors

null

Xiaoting Ma

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China

Xiaoting Ma , Lin Yang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT02504229

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4037)

DOI

10.1200/JCO.2023.41.16_suppl.4037

Abstract #

4037

Poster Bd #

358

Abstract Disclosures

Similar Posters

First Author: Yuhong Dai

First Author: Kohei Shitara

First Author: Yelena Y. Janjigian

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Impact of adding nivolumab to first-line chemotherapy in patients with advanced gastric cancer.

Impact of adding nivolumab to first-line chemotherapy in patients with advanced gastric cancer.

First Author: Mai Utsumi